CClinicalTrials.gg
CompletedNCT02943538TECCUUpdated Jan 18, 2017

Telemedicine Crohn's Disease and Ulcerative Colitis (TECCU)

An interventional study of Telemedicine and Telephone in Crohn's Disease and Colitis, Ulcerative, sponsored by Instituto de Investigacion Sanitaria La Fe. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-01-18.

Sponsored by Instituto de Investigacion Sanitaria La Fe · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Pragmatic clinical trial, randomized, controlled parallel, 3 group (group technology platform, call group and control group), developed in the monograph Reference Unit of Inflammatory Bowel Disease Valencia (single-center).

Read the detailed description

Hypothesis: The interventions follow-up of patients with Crohn's Disease or Ulcerative Colitis active moderate-high complexity based on the incorporation of information technologies and communication, to improve monitoring of the presence of inflammatory activity, adherence to treatment and drug toxicity, increase the proportion of inactive patients (clinical remission) at 6 months follow-up and thus improve clinical outcomes and health outcomes (HRQOL, satisfaction) and reduces the consumption of health resources.

Goals:

  • Primary: To assess the effectiveness of intervention Teccu to achieve clinical remission of IBD patients with moderate-high compared to usual care to these patients (G_control) and assisted call with nurses (G_AT) complexity.
  • Secondary: - To evaluate the effectiveness of interventions to improve HRQOL and satisfaction with treatment in patients GTECCU intervention group compared to G_control and G_AT in the 6 months follow up. - To assess the safety of the intervention Teccu judging by adverse events that require a doctor's visit or unscheduled nursing. - Describe the use of health resources (surgeries, hospitalizations, emergency room visits and outpatient visits) by patients of G-Teccu, G_control and G_AT in the 6 months follow up. - Evaluate the effectiveness of intervention in the reduction of a combined endpoint of hospital emergency room visits and unscheduled patients in the intervention group compared to G-Teccu G_control and G_AT within 6 months of follow-up consultations.

Description:

The proposed intervention is based on the extent of chronic GeCronic program that is currently being developed at the Hospital La Fe de Valencia for comprehensive management of chronic conditions of high complexity using the technology platform NOMHAD. NOMHADchronic is a system designed to allow management services to deploy chronically ill supported by technology. The product consists of different modules that seek to cover all aspects of that management: clinical information on the status of patients according to their respective conditions, support for the coordination of the actors during the care process, logistics management and human resources, integration with accessories and monitoring devices. Of all the modules of the platform, NOMHADcore out as the module which houses all the functionality on clinical and care management of patients. There follows a detailed description of the module, its structure and operation.

02

Conditions studied

  • Crohn's Disease
  • Colitis, Ulcerative

Keywords

  • Crohn's Disease
  • Colitis, Ulcerative
  • Telemedicine
03

In context

Colitis

1,073 studies on the registry are indexed under Colitis; 131 are open to participants now.

This study's enrollment of 60 is close to the median of 60 across 771 interventional studies indexed under Colitis.

Browse Colitis studies →

Lead sponsor

Instituto de Investigacion Sanitaria La Fe is the lead sponsor of 57 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients aged ≥18 years.
  • Inflammatory Bowel Disease at least 6 months duration, diagnosed according to the classical criteria of Lennard-Jones
  • Patients with Crohn's Disease or Ulcerative Colitis with moderate or severe activity (as Harvey-Bradshaw index and May, respectively) attending IBD unit during the period of inclusion.
  • Patients who initiate medical treatment with immunosuppressive drugs or biological agents, or are undergoing surgical treatment (surgery is considered as a treatment for EC).
  • Patient consents to participate in the study and sign and date personally indicating that it has been informed of all pertinent aspects of the study.
  • Patient not incur the exclusion criteria

Exclusion criteria

Exclusion Criteria:

  • Patients with cognitive or sensory impairments or with insufficient command of the two official languages of Valencia, in the opinion of the health professional conduct recruitment, hinder the understanding of the issues raised in the surveys, scales or instruments used in the study always who do not have a legal representative
  • Patients who are unable to handle a mobile phone to participate in the study. - Patients who do not have a phone line because, if they are assigned to G_TECCU or G_AT groups could not be implemented appropriate interventions.
  • They are participating at the time of recruitment in any other clinical trial or experimental study. Exclusion criteria will not be participating in observational studies
  • Terminals and / or palliative care according to the criteria of the SECPAL (Spanish Society of Palliative Care) Patients
  • Patients institutionalized
  • They are members of the research team, the staff of the research center or health centers involved in the study, or any other person directly involved in the study.
  • Relatives in the first degree of consanguinity or affinity of members of the research team, the staff of the research center or health centers involved in the study, or any other person directly involved in the study
  • Patients presenting as primary diagnosis mental illness
  • Patients with active cancer diagnosis
  • Patients in the assessment of professional performing recruitment not considered likely to be included for specific monitoring found in another unit such as hemodialysis, transplant unit, day hospital ...
  • Patients who do not agree to participate in the study or not to sign the corresponding informed consent
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Telemedicine group

    In this group, monitoring and control is performed through telematics platform integrated management of chronic NOMHAD, configurated to respond the patients specific needs.

    Device: Telemedicine

  • Experimental
    Telephone support group

    A telephone control of their state and evolution will be made through the nursing staff of the unit.

    Device: Telephone

  • Active comparator
    Control group

    Conventional care provided in the unit to patients with IBD -high moderate complexity.

    Other: Conventional care

Interventions

  • DeviceTelemedicine

    Monitoring and control is performed through telematics platform integrated management of chronic NOMHAD, configurated to respond the patients specific needs.

  • DeviceTelephone

    A telephone control of their state and evolution will be made through the nursing staff of the unit.

  • OtherConventional care

    Conventional care provided in the unit to patients with IBD -high moderate complexity.

06

What researchers measure

Primary outcomes

  1. Clinical Remission

    Clinical remission of patients at 6 months of follow-up using Harvey-Bradshaw index for Crohn's disease.

    Time frame: 6 months

  2. Clinical Remission

    Clinical remission of patients at 6 months of follow-up using May index for ulcerative colitis.

    Time frame: 6 months

Secondary outcomes

  1. Health-Related Quality of Life

    Health-Related Quality of Life measured by the generic Euroqol (EQ-5D) questionaire

    Time frame: 6 months

  2. Health-Related Quality of Life

    Health-Related Quality of Life measured by the specific IBD in its reduced version (SIBDQ: Short Inflammatory Bowel Disease Questionnaire).

    Time frame: 6 months

  3. Patient Satisfaction

    Measured by a satisfaction questionaire designed for the study.

    Time frame: 6 months

  4. Therapeutic adherence

    Measured by the validated Morisky-Green questionaire.

    Time frame: 6 months

  5. Urgent and scheduled visits and urgent hospital admissions

    Urgent and scheduled visits and urgent hospital admissions in the follow-up period will be captured directly systems hospital information (HIS).

    Time frame: 6 months

  6. Number of surgical interventions related with the pathology

    Time frame: 6 months

  7. Work activity and productivity (Cronh patients)

    Worrk activity and productivity measured by a validate questionaire: Vergara M. et al. Value Health 2011;14(6):859-61).

    Time frame: 6 months

  8. Mortality

    Time frame: 6 months

  9. Directs health costs

    Time frame: 6 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Del Hoyo J, Nos P, Bastida G, Faubel R, Munoz D, Garrido-Marin A, Valero-Perez E, Bejar-Serrano S, Aguas M. Telemonitoring of Crohn's Disease and Ulcerative Colitis (TECCU): Cost-Effectiveness Analysis. J Med Internet Res. 2019 Sep 13;21(9):e15505. doi: 10.2196/15505. PubMed 31538948 ↗
  • Aguas M, Del Hoyo J, Faubel R, Munoz D, Dominguez D, Bastida G, Navarro B, Barrios A, Valdivieso B, Correcher M, Nos P. A Web-Based Telemanagement System for Patients With Complex Inflammatory Bowel Disease: Protocol for a Randomized Controlled Clinical Trial. JMIR Res Protoc. 2018 Dec 21;7(12):e190. doi: 10.2196/resprot.9639. PubMed 30578197 ↗
  • Del Hoyo J, Nos P, Faubel R, Munoz D, Dominguez D, Bastida G, Valdivieso B, Correcher M, Aguas M. A Web-Based Telemanagement System for Improving Disease Activity and Quality of Life in Patients With Complex Inflammatory Bowel Disease: Pilot Randomized Controlled Trial. J Med Internet Res. 2018 Nov 27;20(11):e11602. doi: 10.2196/11602. PubMed 30482739 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 18, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02943538
Lead sponsor
Instituto de Investigacion Sanitaria La Fe
Responsible party
Sponsor
First posted
Oct 24, 2016
Start date
May 2014
Primary completion
Dec 2016
Completion
Dec 2016
Last update
Jan 18, 2017

Study contacts

Marian Aguas
principal investigator · Instituto de Investigación Sanitaria La Fe

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion